TrialTrials2017

First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial.

Christian Grønhøj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.